SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
van Es Charles
(Last) (First) (Middle)
250 PARK AVE SOUTH
SEVENTH FLOOR
(Street)
NEW YORK NY 10003
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Sales Officer
3. Date of Earliest Transaction (Month/Day/Year)
11/29/2022
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/29/2022 S(1) 3,862 D $11.2893 93,065 D
Common Stock 12/01/2022 S(2) 5,721 D $12.339(3) 87,344(4) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy) $10.178 (5) 12/16/2029 Common Stock 129,675 129,675 D
Non-Qualified Stock Option (right to buy) $10.178 (6) 02/10/2030 Common Stock 113,750 113,750 D
Non-Qualified Stock Option (right to buy) $10.178 (7) 01/11/2031 Common Stock 27,300 27,300 D
Non-Qualified Stock Option (right to buy) $15 (8) 10/21/2031 Common Stock 58,043 58,043 D
Non-Qualified Stock Option (right to buy) $15.36 (9) 08/15/2032 Common Stock 42,980 42,980 D
Explanation of Responses:
1. The sales reported represent shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting of restricted stock units previously granted to the reporting person.
2. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
3. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.12 to $12.42, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
4. These shares consist of unvested restricted stock units. The reporting person initially reported the restricted stock units relating to this vesting in Table II of Form 4. The total reported in Column 5 reflects 38,333 restricted stock units previously reported in Table II minus those shares that were sold as indicated on this Form 4.
5. The stock option is fully vested and currently exercisable.
6. The stock option is fully vested and currently exercisable with respect to 56,875 underlying shares. The remainder will vest on February 10, 2024.
7. The stock option vests in two equal installments on January 11, 2023 and January 11, 2025.
8. The stock option vests in four equal annual installments beginning on November 27, 2022.
9. The stock option vests in three equal annual installments beginning on August 15, 2025.
By: Yolanda Goettsch, Attorney-in-Fact For: Charles Van Es 12/01/2022
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.